Treatment of pediatric antimuscarinic delirium with oral rivastigmine
Treatment of pediatric antimuscarinic delirium with oral rivastigmine is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Treatment of pediatric antimuscarinic delirium with oral rivastigmine have?
Treatment of pediatric antimuscarinic delirium with oral rivastigmine has 7 citations in the OpenAlex counts ScholarIQ stores.
When was Treatment of pediatric antimuscarinic delirium with oral rivastigmine published?
Treatment of pediatric antimuscarinic delirium with oral rivastigmine has 2023 year in the ScholarIQ index.
What is the open-access status of Treatment of pediatric antimuscarinic delirium with oral rivastigmine?
Treatment of pediatric antimuscarinic delirium with oral rivastigmine has gold oa status in the ScholarIQ index.
What is the DOI of Treatment of pediatric antimuscarinic delirium with oral rivastigmine?
The DOI for Treatment of pediatric antimuscarinic delirium with oral rivastigmine is on the source record.
What is the PMID of Treatment of pediatric antimuscarinic delirium with oral rivastigmine?
The PMID for Treatment of pediatric antimuscarinic delirium with oral rivastigmine is on the source record.
What is the OpenAlex record for Treatment of pediatric antimuscarinic delirium with oral rivastigmine?
The OpenAlex for Treatment of pediatric antimuscarinic delirium with oral rivastigmine is on the source record.